Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FILTROX is a Swiss filtration technology company focused on depth filtration and microfiltration solutions for high-value liquids. The company develops and manufactures filter media, filter modules, filter sheets, housings, filter presses, cartridges, and related systems used across life sciences, pharmaceuticals, biotechnology, chemicals, food and beverage, and other process industries. In healthcare-related markets, FILTROX provides clarification, bioburden reduction, and sterile-oriented filtration solutions, including single-use products and pharma-grade equipment for sensitive manufacturing applications. The business is not a drug developer; rather, it is a commercial supplier of filtration technologies, application support, and validation-oriented services used in bioprocessing and pharmaceutical production. FILTROX appears to be an active, privately held, family-owned company headquartered in St. Gallen, Switzerland, with an international operating footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FILTROX.